Cargando…
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
Head and Neck cancers (HNC) are a heterogeneous group of upper aero-digestive tract cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of these cancers are of squamous cell origin (HNSCC). HNSCC is associated with excessive tobacco and alcohol consumption and infection...
Autores principales: | Huang, Xiaomin, Duijf, Pascal H. G., Sriram, Sharath, Perera, Ganganath, Vasani, Sarju, Kenny, Lizbeth, Leo, Paul, Punyadeera, Chamindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413618/ https://www.ncbi.nlm.nih.gov/pubmed/37559138 http://dx.doi.org/10.1186/s12929-023-00953-z |
Ejemplares similares
-
Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges
por: Basnayake, B. W. M. Thilini J., et al.
Publicado: (2023) -
Application of circulating tumour cells to predict response to treatment in head and neck cancer
por: Zhang, Xi, et al.
Publicado: (2022) -
DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers
por: Ekanayake Weeramange, Chameera, et al.
Publicado: (2020) -
An Occult HPV-Driven Oropharyngeal Squamous Cell Carcinoma Discovered Through a Saliva Test
por: Tang, Kai Dun, et al.
Publicado: (2020) -
PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017)